These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34407729)

  • 21. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
    Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
    Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
    Laothaworn V; Juntongjin P
    J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
    [No Abstract]   [Full Text] [Related]  

  • 23. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
    Moubasher AE; Youssef EM; Abou-Taleb DA
    Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractional Erbium-Doped Yttrium Aluminum Garnet Laser Versus Microneedling in Treatment of Atrophic Acne Scars: A Randomized Split-Face Clinical Study.
    Osman MA; Shokeir HA; Fawzy MM
    Dermatol Surg; 2017 Jan; 43 Suppl 1():S47-S56. PubMed ID: 28009690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser.
    Abdel Hay R; Mohammed FN; Sayed KS; Abd El Fattah NA; Ibrahim S
    Dermatol Ther; 2020 Jul; 33(4):e13629. PubMed ID: 32431000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid.
    Lim JT
    Dermatol Surg; 1999 Apr; 25(4):282-4. PubMed ID: 10417583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of the combination of Q-switched Nd:YAG laser and microneedling for melasma.
    Karadağ Köse Ö; Borlu M
    J Cosmet Dermatol; 2021 Mar; 20(3):769-775. PubMed ID: 32696614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
    Hawwam SA; Ismail M; El-Attar YA
    Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
    Tourlaki A; Galimberti MG; Pellacani G; Bencini PL
    J Dermatolog Treat; 2014 Jun; 25(3):218-22. PubMed ID: 22385073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: A split-face study.
    Mekawy KMM; Sadek A; Seddeik Abdel-Hameed AK
    J Cosmet Dermatol; 2021 Feb; 20(2):460-465. PubMed ID: 32562337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
    Chalermchai T; Rummaneethorn P
    J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined fractional ablative and nonablative laser resurfacing treatment: a split-face comparative study.
    Cohen JL; Ross EV
    J Drugs Dermatol; 2013 Feb; 12(2):175-8. PubMed ID: 23377390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periorbital rejuvenation with fractional 1,550-nm ytterbium/erbium fiber laser and variable square pulse 2,940-nm erbium:YAG laser in Asians: a comparison study.
    Wattanakrai P; Pootongkam S; Rojhirunsakool S
    Dermatol Surg; 2012 Apr; 38(4):610-22. PubMed ID: 22268427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma.
    Park KY; Kim DH; Kim HK; Li K; Seo SJ; Hong CK
    Clin Exp Dermatol; 2011 Dec; 36(8):864-70. PubMed ID: 21973194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of combined treatment with intense pulsed light and fractional erbium:YAG Laser in scar prevention: A randomized split wound trial.
    Kim JC; Kang SY; Kim HO; Park CW; Kwon O; Chung BY
    Dermatol Ther; 2021 Sep; 34(5):e15061. PubMed ID: 34250712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
    Lueangarun S; Namboonlue C; Tempark T
    J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma.
    Debasmita B; Raj C; Ishan A; Ipsita D
    J Cosmet Dermatol; 2022 Jul; 21(7):2801-2807. PubMed ID: 34636493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
    Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
    Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature.
    Garg S; Vashisht KR; Makadia S
    J Cosmet Laser Ther; 2019 Aug; 21(5):297-307. PubMed ID: 31010346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.